“Today’s announcement demonstrates both the progress and incredible potential of the company,” says Inari CEO Ponsi Trivisvavet. “We have the ability to enhance any seed for any geography, making our products — and impact — globally scalable.”
The goal is to provide scientists with a large collection of data on the virus so they can better understand it and, eventually, develop a vaccine or treatment for it.
